ArticleNeuro-oncology2018

Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study.

Elke Pfaff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.